The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: A systematic review and meta-analysis

Virology Journal

Volumn 9, Issue , 2012, Pages

  Deng, Min ^a   Zhou, Xin ^a   Gao, Sheng ^b   Yang, Shi Gui ^a   Wang, Bing ^a   Chen, Hua Zhong ^c   Ruan, Bing ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

Author keywords

Hepatitis B virus; Intrauterine transmission; Pregnanc; Telbivudine

Indexed keywords

CREATINE KINASE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; TELBIVUDINE; VIRUS DNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; COCHRANE LIBRARY; CREATINE KINASE BLOOD LEVEL; DATA BASE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMBASE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOPROPHYLAXIS; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; REVIEW; RISK FACTOR; SIDE EFFECT; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; VIREMIA;

ANTIVIRAL AGENTS; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B, CHRONIC; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; THYMIDINE; TREATMENT OUTCOME;

HEPATITIS B VIRUS;

EID: 84865661653     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-185     Document Type: Review

References (40)

1. Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas. Edmunds WJ, Medley GF, Nokes DJ, O'Callaghan CJ, Whittle HC, Hall AJ, Epidemiol Infect 1996 117 313 325 10.1017/S0950268800001497 8870629 (Pubitemid 26345241)
2. Management of hepatitis B in pregnancy: weighing the options. Tran TT, Cleve Clin J Med 2009 76 Suppl 3 25 S29 19465706
3. Hepatitis B and pregnancy: an underestimated issue. Jonas MM, Liver Int 2009 29 Suppl 1 133 139 19207977
4. Passive-active immunization in infants of hepatitis Be antigen-positive mothers. Comparison of the efficacy of early and delayed active immunization. Grosheide PM, del Canho R, Heijtink RA, Nuijten AS, Zwijnenberg J, Bänffer JR, Wladimiroff YW, Botman MJ, Mazel JA, de Gast GC, Am J Dis Child 1993 147 1316 1320 8249953
5. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. Han GR, Cao MK, Zhao W, Jiang HX, Wang CM, Bai SF, Yue X, Wang GJ, Tang X, Fang ZX, J Hepatol 2011 55 1215 1221 10.1016/j.jhep.2011.02.032 21703206
6. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. Xu DZ, Yan YP, Choi BC, Xu JQ, Men K, Zhang JX, Liu ZH, Wang FS, J Med Virol 2002 67 20 26 10.1002/jmv.2187 11920813 (Pubitemid 34260071)
7. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. Li XM, Shi MF, Yang YB, Shi ZJ, Hou HY, Shen HM, Teng BQ, World J Gastroenterol 2004 10 3215 3217 15457579
8. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, et al. J Viral Hepat 2009 16 94 103 10.1111/j.1365-2893.2008.01056.x 19175878
9. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y, World J Gastroenterol 2004 10 910 912 15040044 (Pubitemid 38418373)
10. Interruption of HBV intrauterine transmission: a clinical study. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L, World J Gastroenterol 2003 9 1501 1503 12854150 (Pubitemid 36992341)
11. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL, J Viral Hepat 2003 10 294 297 10.1046/j.1365-2893.2003.00440.x 12823596 (Pubitemid 36801916)
12. Clinical effect and safety of lamivudine in interruption of chronic HBV maternal to infant transmission. Li W, Jiang R, Wei Z, Li Y, Chin Hepatol 2006 11 106 107
13. Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial. Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, et al. Hepatology 2008 47 447 454 18080339 (Pubitemid 351280712)
14. Telbivudine versus lamivudine in patients with chronic hepatitis B. Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, Chen Y, Heathcote EJ, Rasenack J, Bzowej N, et al. N Engl J Med 2007 357 2576 2588 10.1056/NEJMoa066422 18094378 (Pubitemid 350294224)
15. Analysis of prognosis-associated factors in fulminant viral hepatitis during pregnancy in China. Yang Y, Deng L, Li X, Shi Z, Jiang P, Chen D, Yu Y, Wang Z, Tang X, Zhao S, et al. Int J Gynaecol Obstet 2011 114 242 245 10.1016/j.ijgo.2011.03.017 21752374
16. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Shi Z, Li X, Ma L, Yang Y, Int J Infect Dis 2010 14 622 e634 10.1016/j.ijid.2009.09.008 20106694
17. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, HJ M, Control Clin Trials 1996 17 1 12 10.1016/0197-2456(95)00134-4 8721797 (Pubitemid 26120810)
18. Meta-analysis in clinical trials. DerSimonian R, Laird N, Control Clin Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833 (Pubitemid 17189972)
19. Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients]. Zhang LJ, Wang L, Zhonghua Gan Zang Bing Za Zhi 2009 17 561 563 19719910
20. Clinical study of telbivudine to interrupt intrauterine transmission of Hepatitis B virus. Zeng Y, Zhang S, Lou G, Chen J, Shi J, Liu S, Huang J, Chin J Clin Pharmacol Ther 2010 15 443 445
21. Efficacy and safety of telbivudine in preventing mother-to-infant HBV transmission. Zhang Y, Hu Y, Adverse Drug Reactions Journal 2010 12 157 159
22. Effects of Telbivudine joint hepatitis B vaccine and hepatitis B immunoglobulin to interrupt mother-to-child transmission:a randomized controlled trial of 60 cases. Zhao D, Liao X, Peng G, Liu J, Lin C, Chin J Mod Drug Appl 2010 4 37 38
23. The efficacy and safety of telbivudine in blocking intrauterine hepatitis B viral transmission. Yao Z, Chen M, Liao W, Zhang Y, Wu Y, Li L, Feng J, Lin M, Chen C, Zheng D, Zuang J, J Clin Hepatol 2011 14 259 261
24. New research for efficacy of telbivudine blocking HBV transmission from mother to child. Jiang Q, Liang W, Zhang S, Zeng Y, Meng Y, Zhang Y, Lou G, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2010 24 286 288
25. -23 cases of telbivudine joint hepatitis B immunoglobulin to interrupt HBV mother-to-child transmission. Zeng Y, Zhang S, Lou G, Chen J, Shi J, Liu S, Huang J, J Prac Med 2010 26 3012 3014
26. HBV infection in indigenous children, 20 years after immunization in Taiwan: a community-based study. Huang CF, Dai CY, Chuang WL, Ho CK, Wu TC, Hou NJ, Wang CL, Hsieh MY, Huang JF, Lin ZY, et al. Prev Med 2009 48 397 400 10.1016/j.ypmed.2009.02.002 19463479
27. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. Wang Z, Zhang J, Yang H, Li X, Wen S, Guo Y, Sun J, Hou J, J Med Virol 2003 71 360 366 10.1002/jmv.10493 12966540 (Pubitemid 37176624)
28. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. Lee C, Gong Y, Brok J, Boxall EH, Gluud C, BMJ 2006 332 328 336 10.1136/bmj.38719. 435833.7C 16443611 (Pubitemid 43253746)
29. Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review. Shi Z, Yang Y, Wang H, Ma L, Schreiber A, Li X, Sun W, Zhao X, Yang X, Zhang L, et al. Arch Pediatr Adolesc Med 2011 165 837 846 10.1001/archpediatrics.2011.72 21536948
30. Long-term therapeutic efficacy of lamivudine compared with interferon-α in children with chronic hepatitis B: The younger the better. Choe B, Lee J, Jang Y, Jang C, Oh K, Kwon S, Hyun M, Ko C, Lee K, Lee W, J Pediatr Gastroenterol Nutr 2007 44 92 98 10.1097/01.mpg.0000243439.47334.4e 17204960 (Pubitemid 46071799)
31. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, de Gast GC, Fetter WP, Zwijneberg J, Schalm SW, Vaccine 1997 15 1624 1630 10.1016/S0264-410X(97)00080-7 9364693 (Pubitemid 27445742)
32. The role of placenta in hepatitis B virus intrauterine transmission. Yan Y, Xu D, Wang W, Zhonghua Fu Chan Ke Za Zhi 1999 34 392 395 11360645
33. Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBV infection. Yu H, Zhu Q-R, Gu S-Q, Fei L-E, World journal of gastroenterology: WJG 2006 12 2928 2931 16718821 (Pubitemid 43805466)
34. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Shi Z, Yang Y, Ma L, Li X, Schreiber A, Obstet Gynecol 2010 116 147 159 10.1097/AOG.0b013e3181e45951 20567182
35. EASL clinical practice guidelines on the management of chronic hepatitis B: the need for liver biopsy. Papatheodoridis GV, Manolakopoulos S, J Hepatol 2009 51 226 227 10.1016/j.jhep.2009.02.017 19410321
36. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK, Lancet 2002 359 1488 1489 10.1016/S0140-6736(02)08425-8 11988251 (Pubitemid 34457770)
37. Clinical pharmacokinetics of lamivudine. Johnson MA, Moore KH, Yuen GJ, Bye A, Pakes GE, Clin Pharmacokinet 1999 36 41 66 10429839 (Pubitemid 29056000)
38. Dienstag J, Easley C, Kirkpatrick P, Telbivudine. Nature reviews Drug discovery 2007 6 267 268 10.1038/nrd2295 (Pubitemid 46505877)
39. Chronic Hepatitis BGWPotA-PAftSotL: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Liaw Y-F, Leung N, Kao J-H, Piratvisuth T, Gane E, Han K-H, Guan R, Lau GKK, Locarnini S, Hepatology international 2008 2 263 283 10.1007/s12072-008-9080-3 19669255
40. The impact of antepartum injection of hepatitis B immunoglobulin on maternal serum HBV DNA and anti-HBs in the newborns. Han Z-H, Zhong L-H, Wang J, Zhao Q-L, Sun Y-G, Li L-W, Cao L-H, Hao X-C, Zhuang H, Zhonghua nei ke za zhi [Chinese journal of internal medicine] 2007 46 376 378